David Parada
Overview
Explore the profile of David Parada including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
37
Citations
93
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Castane H, Jimenez-Franco A, Hernandez-Aguilera A, Martinez-Navidad C, Cambra-Cortes V, Onoiu A, et al.
EBioMedicine
. 2024 Dec;
111():105532.
PMID: 39731853
Background: Metabolic dysfunction-associated steatotic liver disease (MASLD) and its more severe form steatohepatitis (MASH) contribute to rising morbidity and mortality rates. The storage of fat in humans is closely associated...
2.
Arto C, Rusu E, Clavero-Mestres H, Barrientos-Riosalido A, Bertran L, Mahmoudian R, et al.
Eur J Clin Invest
. 2024 Jun;
54(11):e14279.
PMID: 38940215
Background And Aims: The rise in obesity highlights the need for improved therapeutic strategies, particularly in addressing metabolic dysfunction-associated steatotic liver disease (MASLD). We aim to assess the role of...
3.
Bernet-Vegue L, Cantero-Gonzalez C, Sancho de Salas M, Parada D, Perin T, Quintero-Nino Z, et al.
Clin Transl Oncol
. 2023 Dec;
26(5):1220-1228.
PMID: 38070048
Purpose: This study aimed to validate the classification of breast cancer (BC) patients in progression risk groups based on total tumor load (TTL) value to predict lymph node (LN) affectation...
4.
Fernandez-Castillejo S, Roig B, Mele M, Serrano S, Salvat M, Querol M, et al.
J Med Genet
. 2023 Aug;
61(1):69-77.
PMID: 37591735
Background: Multigene panel testing by next-generation sequencing (MGP-NGS) enables the detection of germline pathogenic or likely pathogenic variants (PVs/LPVs) in genes beyond those associated with a certain cancer phenotype. Opportunistic...
5.
Pena K, Riu F, Hernandez A, Guilarte C, Elizalde-Horcada M, Parada D
Biomedicines
. 2023 Jun;
11(6).
PMID: 37371673
In patients with advanced cancer, it is necessary to detect driver mutations and genetic arrangements. If a mutation is found, targeted therapy may become an option. However, in most patients...
6.
Pique B, Pena K, Riu F, Acosta J, Torres-Royo L, Malave B, et al.
J Clin Med
. 2023 Feb;
12(3).
PMID: 36769445
Several studies have shown that the plasma RNA of SARS-CoV-2 seems to be associated with a worse prognosis of COVID-19. In the present study, we investigated plasma RNA in COVID-19...
7.
Guma J, Pena K, Riu F, Lucia-Gozalvez C, Vidaller A, Maldonado V, et al.
Pathobiology
. 2023 Feb;
90(4):281-288.
PMID: 36731433
Introduction: Liquid biopsy is an innovative and efficient method for studying circulating tumor DNA. In conjunction with innovative techniques such as next-generation sequencing, it can provide real-time information on prognostic...
8.
Barrientos-Riosalido A, Real M, Bertran L, Aguilar C, Martinez S, Parada D, et al.
Int J Mol Sci
. 2023 Jan;
24(2).
PMID: 36674839
The autophagy gene has been shown to be essential for the induction of autophagy, a process that used to be suppressed in nonalcoholic fatty liver disease (NAFLD). However, the specific...
9.
Pena K, Riu F, Guma J, Martinez-Madueno F, Miranda M, Vidal A, et al.
J Clin Med
. 2022 Dec;
11(24).
PMID: 36556046
Muscle-invasive urothelial carcinoma represents 20% of newly diagnosed cases of bladder cancer, and most cases show aggressive biological behavior with a poor prognosis. It is necessary to identify biomarkers that...
10.
Galceran J, Parada D, Eden M, Tumino R, Warren A, Martos C, et al.
Front Oncol
. 2022 Dec;
12:1046239.
PMID: 36505871
An updated European Network of Cancer registries (ENCR) Recommendations on Recording and Reporting of Urothelial Tumours of the Urinary Tract had been published in 2022. After the publication by the...